Jiangsu Gdk Biological Technology Co., Ltd

Company Profile

Sector

Healthcare

Industry

Biotechnology

Employees

390

Website

www.gdkbio.com

Country

China

Exchange

Shanghai

Founded 2008

Jiangsu Gdk Biological Technology researches, develops, produces, and sells human vaccines. It offers quadrivalent influenza virus split vaccines. The company human vaccine products are used for the prevention of various infectious diseases, including influenza, rabies, chickenpox, shingles, and pneumonia. Founded in 2008, Jiangsu Gdk Biological Technology is based in Taizhou, China.

Key Stats

52-Week Range

¥12.50¥31.20

Beta0.22

Trailing P/EN/A

Forward P/EN/A

Trailing EPS-1.49

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceN/A

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.